Seres Therapeutics Inc.

MCRB | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.10

+$0.03 (+0.74%)

Sep 22, 2026, 1:30 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	45.77M	30.79M	127.97M	163.03M	180M	116.05M
Short-Term Investments	n/a	n/a	n/a	18.31M	110.7M	137.57M
Long-Term Investments	8.67M	8.67M	9.59M	9.59M	495K	49.83M
Other Long-Term Assets	31K	31K	65.57M	10.47M	14.59M	1.4M
Receivables	360K	4.75M	n/a	n/a	n/a	9.39M
Inventory	n/a	n/a	29.65M	n/a	n/a	n/a
Other Current Assets	3.25M	3.13M	17.8M	13.42M	n/a	n/a
Total Current Assets	49.38M	38.67M	175.41M	194.76M	303.63M	268.78M
Property-Plant & Equipment	80.12M	92.44M	108.03M	133.97M	36.15M	22.94M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	88.82M	101.14M	183.19M	154.02M	51.23M	74.16M
Total Assets	138.19M	139.81M	358.6M	348.78M	354.86M	342.94M
Account Payables	1.68M	4.08M	3.64M	17.44M	13.74M	4.02M
Deferred Revenue	n/a	n/a	7.73M	4.26M	16.82M	22.6M
Short-Term Debt	10.39M	n/a	n/a	456K	n/a	454K
Other Current Liabilities	4.57M	17.75M	59.19M	34.77M	21.1M	n/a
Total Current Liabilities	19.32M	41.22M	98.66M	85.6M	82.26M	46.42M
Long-Term Debt	n/a	n/a	101.54M	50.59M	24.64M	24.64M
Other Long-Term Liabilities	2.08M	1.84M	16.24M	1.44M	11.5M	1M
Total Long-Term Liabilities	74.65M	84.8M	304.8M	252.41M	141.09M	121.78M
Total Liabilities	93.98M	126.03M	403.46M	338M	223.35M	168.19M
Total Debt	82.97M	91.64M	198.78M	162.59M	49.21M	40.77M
Book Value	44.22M	13.78M	-44.86M	10.78M	131.51M	174.75M
Book Value Per Share	4.99	1.77	-7.01	2	28.68	43.80
Common Stock	10K	173K	135K	125K	92K	91K
Retained Earnings	-972.4M	-978.1M	-978.24M	-864.51M	-614.35M	-548.78M
Comprehensive Income	n/a	n/a	n/a	-12K	-60K	-47K
Shareholders Equity	44.22M	13.78M	-44.86M	10.78M	131.51M	174.75M
Total Investments	8.67M	8.67M	9.59M	27.9M	111.2M	187.39M